Skip to main content

LIVE

ZBH

Zimmer Biomet Holdings, Inc.

ZBH

NYSE·Healthcare·Medical - Devices·Mkt cap $19.2B

$100.93

+1.54%

P/E

24.56

Mkt Cap

$19.2B

52-Wk Range

$79.12–$106.88

52-Week Range

$79.12 - $106.88

P/E

24.56

Fwd P/E

11.83

Beta

0.46

Div Yield

0.97%

Avg Vol

2.4M

Shares Out

193.6M

Mkt Cap

$19.2B

Price action

Price chart

Down 5.3% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Extensive product portfolio
  • Advanced robotic surgical technologies
  • Global distribution network
  • Continuous research and innovation

Bear Case

1 risk

  • Low volatility (beta 0.5).

Growth

Stable outlook

Aging global population

Value

Undervalued - trading well below Medical Devices peers

Momentum

Strong

+18.7% over 3m

Quality

Excellent

Excellent business quality

Dividend

Modest

0.97% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 4, 2026

Q3 26 RECAP

AUG 5, 2026

Reported EPS of $2.07 vs $2.01 consensus (+3.0% surprise). Revenue of $2.2B vs $2.1B expected (+2.0%). Beat on both top and bottom lines.

EPS beat +3.0%
Rev beat +2.0%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+3.0%

Revenue trend · last 8Q

+4%

+1%

+7%

+10%

+11%

+9%

+5%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$1.8B

$2.0B

$1.9B

$2.1B

$2.0B

$2.2B

$2.1B

$2.2B

Margins · last 8Q

Gross

70.8%

Operating

15.0%

Profit

9.1%

Wall Street consensus

12 analysts · 33% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

4

33%

Hold

7

58%

Sell

1

8%

Median Price Target

Latest: UBS · Aug 6, 2026

vs Industry

How ZBH stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.